Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2022Frontiers in ImmunologyOpen Access

A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLele MiaoJining First People's HospitalJZJuan ZhangHebei Medical UniversityZZZhengchao ZhangFujian Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miao et al. (2022) studied this question.

synapsesocial.com/papers/6a7afd52a861e9f59932cdachttps://doi.org/10.3389/fimmu.2022.840956
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation2020 · 13 citations
  2. 2Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma2015 · 774 citations
  3. 3Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma2015 · 1,003 citations
  4. 4Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia2014 · 5,505 citations